These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The management of thrombosis in pregnancy: role of low-molecular-weight heparin. Kher A, Bauersachs R, Nielsen JD. Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011 [Abstract] [Full Text] [Related]
3. Use of low molecular weight heparin in pregnant women with mechanical heart valves. Yinon Y, Siu SC, Warshafsky C, Maxwell C, McLeod A, Colman JM, Sermer M, Silversides CK. Am J Cardiol; 2009 Nov 01; 104(9):1259-63. PubMed ID: 19840573 [Abstract] [Full Text] [Related]
4. Thromboembolism in pregnancy: an overview. Girling JC, de Swiet M. Curr Opin Obstet Gynecol; 1996 Dec 01; 8(6):458-63. PubMed ID: 8979019 [Abstract] [Full Text] [Related]
8. The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey. Voke J, Keidan J, Pavord S, Spencer NH, Hunt BJ, British Society for Haematology Obstetric Haematology Group. Br J Haematol; 2007 Nov 01; 139(4):545-58. PubMed ID: 17916101 [Abstract] [Full Text] [Related]
15. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review. Duhl AJ. J Reprod Med; 2008 Sep 01; 53(9):657-66. PubMed ID: 18839817 [Abstract] [Full Text] [Related]
16. [Anticoagulants and thrombolytic agents in pregnancy and puerperium]. Appel W. Z Allgemeinmed; 1971 Mar 10; 47(7):345-50. PubMed ID: 5558582 [No Abstract] [Full Text] [Related]